Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential photodynamic therapy and diclofenac gel for actinic keratosis
2013-000110-37Phase 4Active
- Sponsor
- Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal
- Start
- Mar 2013
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of diclofenac and methyl aminolevulinate in actinic keratosis (AK) (2 arms), sponsored by Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal. Primary endpoint: Significant clinical response. Started Mar 2013; status: active.
02
Drugs
diclofenacmethyl aminolevulinate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2013-000110-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000110-37.